The DOI matches its Crossref record; 78 of the 78 references it cites were found in a registry or an index.
Glutamate and the biology of gliomas
Open accessAbstract
Several important and previously unrecognized roles for the neurotransmitter glutamate in the biology of primary brain tumors have recently been elucidated. Glutamate is produced and released from glioma cells via the system x c− cystine glutamate transporter as a byproduct of glutathione synthesis. Glutamate appears to play a central role in the malignant phenotype of glioma via multiple mechanisms. By binding to peritumoral neuronal glutamate receptors, glutamate is responsible for seizure induction and similarly causes excitotoxicity, which aids the expansion of tumor cells into the space vacated by destroyed tissue. Glutamate also activates ionotropic and metabotropic glutamate receptors on glioma cells in a paracrine and autocrine manner. α‐Amino‐3‐hydroxy‐5‐methyl‐4‐isoaxazolepropionate acid (AMPA) glutamate receptors lack the GluR2 subunit rendering them Ca 2+ permeable and capable of activating the AKT and MAPK pathways. Furthermore, these receptors are critical in aiding the invasion of glioma cells into normal brain. AMPA‐Rs accumulate at focal adhesion sites where they may indirectly mediate interactions between the extracellular matrix and integrins. Glutamate receptor stimulation results in activation of focal adhesion kinase, which is critical to the regulation of growth factor and integrin‐stimulated cell motility and invasion. The multitude of effects of glutamate on glioma biology supports the rationale for pharmacological targeting of glutamate receptors and transporters. Several ongoing and recently completed clinical trials are exploring the therapeutic potential of interrupting glutamate‐mediated brain tumor growth. © 2010 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Glutamate neurotoxicity and diseases of the nervous system
CHOI, D. (1988) · Neuron · doi:10.1016/0896-6273(88)90162-6 · Cited by 7,972
Danbolt, N. C. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(00)00067-8 · Cited by 4,227
AMPA Receptor Trafficking and Synaptic Plasticity
Malinow, R., & Malenka, R. C. (2002) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.25.112701.142758 · Cited by 2,588
A Perivascular Niche for Brain Tumor Stem Cells
Calabrese, C., Poppleton, H., Kocak, M., Hogg, T. L., Fuller, C., Hamner, B., Oh, E. Y., Gaber, M. W., Finklestein, D., Allen, M., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2006.11.020 · Cited by 2,197
Wise, D. R., DeBerardinis, R. J., Mancuso, A., Sayed, N., Zhang, X.-Y., Pfeiffer, H. K., Nissim, I., Daikhin, E., Yudkoff, M., McMahon, S. B., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810199105 · Cited by 2,001
β-Lactam antibiotics offer neuroprotection by increasing glutamate transporter expression
Rothstein, J. D., Patel, S., Regan, M. R., Haenggeli, C., Huang, Y. H., Bergles, D. E., Jin, L., Dykes Hoberg, M., Vidensky, S., Chung, D. S., et al. (2005) · Nature · doi:10.1038/nature03180 · Cited by 1,518
MAPK cascade signalling and synaptic plasticity
Thomas, G. M., & Huganir, R. L. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1346 · Cited by 1,454
Sato, H., Tamba, M., Ishii, T., & Bannai, S. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.17.11455 · Cited by 1,109
The release and uptake of excitatory amino acids
Nicholls, D., & Attwell, D. (1990) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(90)90129-v · Cited by 1,085
Glutathione in Cancer Biology and Therapy
Estrela, J. M., Ortega, A., & Obrador, E. (2006) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408360500523878 · Cited by 1,041
Modulation of Neuronal Migration by NMDA Receptors
Komuro, H., & Rakic, P. (1993) · Science · doi:10.1126/science.8096653 · Cited by 1,041
Functional Hemichannels in Astrocytes: A Novel Mechanism of Glutamate Release
Ye, Z.-C., Wyeth, M. S., Baltan-Tekkok, S., & Ransom, B. R. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-09-03588.2003 · Cited by 704
Swelling-induced release of glutamate, aspartate, and taurine from astrocyte cultures
Kimelberg, H., Goderie, S., Higman, S., Pang, S., & Waniewski, R. (1990) · The Journal of Neuroscience · doi:10.1523/jneurosci.10-05-01583.1990 · Cited by 690
Glutamate release promotes growth of malignant gliomas
Takano, T., Lin, J. H.-C., Arcuino, G., Gao, Q., Yang, J., & Nedergaard, M. (2001) · Nature Medicine · doi:10.1038/nm0901-1010 · Cited by 601
Glioblastoma multiforme: a review of where we have been and where we are going
Adamson, C., Kanu, O. O., Mehta, A. I., Di, C., Lin, N., Mattox, A. K., & Bigner, D. D. (2009) · Expert Opinion on Investigational Drugs · doi:10.1517/13543780903052764 · Cited by 550
Role of MAP kinase in tumor progression and invasion
Reddy, K. B., Nabha, S. M., & Atanaskova, N. (2003) · Cancer and Metastasis Reviews · doi:10.1023/a:1023781114568 · Cited by 509
Vulnerability of oligodendroglia to glutamate: pharmacology, mechanisms, and prevention
Oka, A., Belliveau, M., Rosenberg, P., & Volpe, J. (1993) · The Journal of Neuroscience · doi:10.1523/jneurosci.13-04-01441.1993 · Cited by 504
Selective induction of astrocytic gliosis generates deficits in neuronal inhibition
Ortinski, P. I., Dong, J., Mungenast, A., Yue, C., Takano, H., Watson, D. J., Haydon, P. G., & Coulter, D. A. (2010) · Nature Neuroscience · doi:10.1038/nn.2535 · Cited by 495
Glioma cells release excitotoxic concentrations of glutamate.
Ye, Z., & Sontheimer, H. W. (1999) · PubMed · Cited by 454
Self-citationYang, C., Sudderth, J., Dang, T., Bachoo, R. G., McDonald, J. G., & DeBerardinis, R. J. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-2266 · Cited by 430
c-Myc Is Required for Maintenance of Glioma Cancer Stem Cells
Wang, J., Wang, H., Li, Z., Wu, Q., Lathia, J. D., McLendon, R. E., Hjelmeland, A. B., & Rich, J. N. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003769 · Cited by 429
Rajasekhar, V. K., Viale, A., Socci, N. D., Wiedmann, M., Hu, X., & Holland, E. C. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00395-2 · Cited by 420
A multigene predictor of outcome in glioblastoma
Colman, H., Zhang, L., Sulman, E. P., McDonald, J. M., Shooshtari, N. L., Rivera, A., Popoff, S., Nutt, C. L., Louis, D. N., Cairncross, J. G., et al. (2010) · Neuro-Oncology · doi:10.1093/neuonc/nop007 · Cited by 386
Neurotransmitters as early signals for central nervous system development
Nguyen, L., Rigo, J.-M., Rocher, V., Belachew, S., Malgrange, B., Rogister, B., Leprince, P., & Moonen, G. (2001) · Cell and Tissue Research · doi:10.1007/s004410000343 · Cited by 371
Genetic alterations and signaling pathways in the evolution of gliomas
Ohgaki, H., & Kleihues, P. (2009) · Cancer Science · doi:10.1111/j.1349-7006.2009.01308.x · Cited by 355
Ye, Z.-C., Rothstein, J. D., & Sontheimer, H. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-24-10767.1999 · Cited by 352
Self-citationAutocrine Glutamate Signaling Promotes Glioma Cell Invasion
Lyons, S. A., Chung, W. J., Weaver, A. K., Ogunrinu, T., & Sontheimer, H. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-2034 · Cited by 342
Self-citationRoles of NMDA receptor activity and nitric oxide production in brain development
Contestabile, A. (2000) · Brain Research Reviews · doi:10.1016/s0165-0173(00)00018-7 · Cited by 338
Ishiuchi, S., Tsuzuki, K., Yoshida, Y., Yamada, N., Hagimura, N., Okado, H., Miwa, A., Kurihara, H., Nakazato, Y., Tamura, M., et al. (2002) · Nature Medicine · doi:10.1038/nm746 · Cited by 325
Vesicular transmitter release from astrocytes
Montana, V., Malarkey, E. B., Verderio, C., Matteoli, M., & Parpura, V. (2006) · Glia · doi:10.1002/glia.20367 · Cited by 322
Inhibition of Cystine Uptake Disrupts the Growth of Primary Brain Tumors
Chung, W. J., Lyons, S. A., Nelson, G. M., Hamza, H., Gladson, C. L., Gillespie, G. Y., & Sontheimer, H. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.5258-04.2005 · Cited by 316
Self-citationAronica, E., Gorter, J. A., Ijlst‐Keizers, H., Rozemuller, A. J., Yankaya, B., Leenstra, S., & Troost, D. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02657.x · Cited by 305
Glutamate antagonists limit tumor growth
Rzeski, W., Turski, L., & Ikonomidou, C. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.091113598 · Cited by 287
The AMPA receptor interacts with and signals through the protein tyrosine kinase Lyn
Hayashi, T., Umemori, H., Mishina, M., & Yamamoto, T. (1999) · Nature · doi:10.1038/16269 · Cited by 269
The Course of Seizure Disorders in Patients With Malignant Gliomas
Moots, P. L., Maciunas, R. J., Eisert, D. R., Parker, R. A., Laporte, K., & Abou-Khalil, B. (1995) · Archives of Neurology · doi:10.1001/archneur.1995.00540310091021 · Cited by 226
Dzubay, J. A., & Jahr, C. E. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-13-05265.1999 · Cited by 213
Ca2+-Permeable AMPA Receptors Regulate Growth of Human Glioblastoma via Akt Activation
Ishiuchi, S., Yoshida, Y., Sugawara, K., Aihara, M., Ohtani, T., Watanabe, T., Saito, N., Tsuzuki, K., Okado, H., Miwa, A., et al. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.2180-07.2007 · Cited by 194
Expression of glutamate receptor subunits in human cancers
Stepulak, A., Luksch, H., Gebhardt, C., Uckermann, O., Marzahn, J., Sifringer, M., Rzeski, W., Staufner, C., Brocke, K. S., Turski, L., et al. (2009) · Histochemistry and Cell Biology · doi:10.1007/s00418-009-0613-1 · Cited by 193
Savaskan, N. E., Heckel, A., Hahnen, E., Engelhorn, T., Doerfler, A., Ganslandt, O., Nimsky, C., Buchfelder, M., & Eyüpoglu, I. Y. (2008) · Nature Medicine · doi:10.1038/nm1772 · Cited by 192
Robe, P. A., Martin, D. H., Nguyen-Khac, M. T., Artesi, M., Deprez, M., Albert, A., Vanbelle, S., Califice, S., Bredel, M., & Bours, V. (2009) · BMC Cancer · doi:10.1186/1471-2407-9-372 · Cited by 186
Marcus, H. J., Carpenter, K. L. H., Price, S. J., & Hutchinson, P. J. (2010) · Journal of Neuro-Oncology · doi:10.1007/s11060-009-9990-5 · Cited by 186
Knobbe, C. B., Merlo, A., & Reifenberger, G. (2002) · Neuro-Oncology · doi:10.1093/neuonc/4.3.196 · Cited by 186
Grossman, S. A., Ye, X., Chamberlain, M., Mikkelsen, T., Batchelor, T., Desideri, S., Piantadosi, S., Fisher, J., & Fine, H. A. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.21.6895 · Cited by 172
Patel, S. A., Warren, B. A., Rhoderick, J. F., & Bridges, R. J. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2003.08.006 · Cited by 164
Robe, P. A. J. T., Bentires‐Alj, M., Bonif, M., Rogister, B., Deprez, M., Haddada, H., Khac, M.-T. N., Jolois, O., Erkmen, K., Merville, M., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0392 · Cited by 157
Stepulak, A., Sifringer, M., Rzeski, W., Endesfelder, S., Gratopp, A., Pohl, E. E., Bittigau, P., Felderhoff‐Mueser, U., Kaindl, A. M., Bührer, C., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0507679102 · Cited by 149
Roslin, M., Henriksson, R., Bergström, P., Ungerstedt, U., & Bergenheim, A. T. (2003) · Journal of Neuro-Oncology · doi:10.1023/a:1022106910017 · Cited by 148
Knobbe-Thomsen, C. B. (2002) · Neuro-Oncology · doi:10.1215/15228517-4-3-196 · Cited by 146
Glutamatergic Regulation of the p70S6 Kinase in Primary Mouse Neurons
Lenz, G., & Avruch, J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.c500363200 · Cited by 143
Kim, J. Y., Kanai, Y., Chairoungdua, A., Ho, S., Matsuo, H., Kim, D. K., Inatomi, J., Sawa, H., Ida, Y., & Endou, H. (2001) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(01)00338-8 · Cited by 143
Targeting Protein Kinase C: New Therapeutic Opportunities Against High-Grade Malignant Gliomas?
da Rocha, A. B., Mans, D. R. A., Regner, A., & Schwartsmann, G. (2002) · The Oncologist · doi:10.1634/theoncologist.7-1-17 · Cited by 141
Piao, Y., Lu, L., & de Groot, J. (2008) · Neuro-Oncology · doi:10.1215/15228517-2008-094 · Cited by 128
Malignant gliomas: perverting glutamate and ion homeostasis for selective advantage
Sontheimer, H. W. (2003) · Trends in Neurosciences · doi:10.1016/j.tins.2003.08.007 · Cited by 125
Self-citationIWAMOTO, F. M., Kreisl, T. N., Kim, L., Duic, J. P., Butman, J. A., Albert, P. S., & Fine, H. A. (2010) · Cancer · doi:10.1002/cncr.24957 · Cited by 123
Newton, H. B. (2003) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.3.5.595 · Cited by 122
Characterization of oligodendrogliomas using short echo time 1H MR spectroscopic imaging
Rijpkema, M., Schuuring, J., van der Meulen, Y. M., van der Graaf, M., Bernsen, H. J. J. A., Boerman, R. H., van der Kogel, A., & Heerschap, A. (2003) · NMR in Biomedicine · doi:10.1002/nbm.807 · Cited by 117
Arcella, A., Carpinelli, G., Battaglia, G., et al. (2005) · Neuro-Oncology · doi:10.1215/s1152851704000961 · Cited by 117
Ferraguti, F., Corti, C., Valerio, E., Mion, S., & Xuereb, J. H. (2001) · Experimental Brain Research · doi:10.1007/s002210000633 · Cited by 115
Ionotropic glutamate receptors in astrocytes
Seifert, G., & Steinhäuser, C. (2001) · Progress in brain research · doi:10.1016/s0079-6123(01)32083-6 · Cited by 105
Reversal or reduction of glutamate and GABA transport in CNS pathology and therapy
Allen, N. J., Káradóttir, R. T., & Attwell, D. (2004) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-004-1318-x · Cited by 100
de Groot, J. D., Liu, T.-J., Fuller, G., & Yung, W. K. A. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3626 · Cited by 97
Behrens, P. F., Langemann, H., Strohschein, R. J., Draeger, J., & Henning, J. (2000) · Journal of Neuro-Oncology · doi:10.1023/a:1006426917654 · Cited by 94
Knockdown of GluR1 expression by RNA interference inhibits glioma proliferation
de Groot, J., Piao, Y., Lu, L., Fuller, G. N., & Yung, W. K. A. (2008) · Journal of Neuro-Oncology · doi:10.1007/s11060-008-9552-2 · Cited by 93
Ułas, J., Satou, T., Ivins, K. J., Kesslak, J. P., Cotman, C. W., & Bal�zs, R. (2000) · Glia · doi:10.1002/(sici)1098-1136(200006)30:4<352::aid-glia40>3.0.co;2-6 · Cited by 85
Wang, Y., & Durkin, J. P. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.39.22783 · Cited by 81
A Novel Pathway for Presynaptic Mitogen-Activated Kinase Activation via AMPA Receptors
Schenk, U., Menna, E., Kim, T.-Y., Passafaro, M., Chang, S., Camilli, P. V. D., & Matteoli, M. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.3074-04.2005 · Cited by 71
Kandil, S. B., Brennan, L., & McBean, G. J. (2010) · Neurochemistry International · doi:10.1016/j.neuint.2010.01.004 · Cited by 56
Improving the prognosis for patients with glioblastoma: the rationale for targeting Src
de Groot, J., & Milano, V. (2009) · Journal of Neuro-Oncology · doi:10.1007/s11060-009-9916-2 · Cited by 54
Relative Expression of mRNAS Coding for Glutaminase Isoforms in CNS Tissues and CNS Tumors
Szeliga, M., Matyja, E., Obara‐Michlewska, M., Grajkowska, W., Czernicki, T., & Albrecht, J. (2007) · Neurochemical Research · doi:10.1007/s11064-007-9507-6 · Cited by 52
Metabotropic glutamate receptor agonists reduce glutamate release from cultured astrocytes
Ye, Z., & Sontheimer, H. W. (1999) · Glia · doi:10.1002/(sici)1098-1136(19990201)25:3<270::aid-glia7>3.0.co;2-v · Cited by 46
Self-citationMetabotropic Glutamate Receptor Expression in Cultured Rat Astrocytes and Human Gliomas
Condorelli, D., Dell'Albani, P., Corsaro, M., Giuffrida, R., Caruso, A., Trovato, S. C., Spinella, F., Nicoletti, F., Albanese, V., & Stella, A. G. (1997) · Neurochemical Research · doi:10.1023/a:1027317319166 · Cited by 44
Neuronal-astrocytic interactions in glutamate metabolism
Schousboe, A., Westergaard, N., & Hertz, L. (1993) · Biochemical Society Transactions · doi:10.1042/bst0210049 · Cited by 44
Mitogenic Signaling and the Relationship to Cell Cycle Regulation in Astrocytomas
Besson, A., & Yong, V. W. (2001) · Journal of Neuro-Oncology · doi:10.1023/a:1010657030494 · Cited by 43
Guo, H. (2002) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.2002.1198 · Cited by 41
Glutamate Promotes Cell Growth by EGFR Signaling on U-87MG Human Glioblastoma Cell Line
Schunemann, D. P., Grivicich, I., Regner, A., Leal, L. F., de Araújo, D. R., Jotz, G. P., Fedrigo, C. A., Simon, D., & da Rocha, A. B. (2009) · Pathology & Oncology Research · doi:10.1007/s12253-009-9223-4 · Cited by 38
Beretta, F., Bassani, S., Binda, E., Verpelli, C., Bello, L., Galli, R., & Passafaro, M. (2009) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2009.06804.x · Cited by 36
Rothstein, J. D. (2002) · Nature Medicine · doi:10.1038/nm0902-938 · Cited by 15
Cited by
Glutamatergic synaptic input to glioma cells drives brain tumour progression
Venkataramani, V., Tanev, D. I., Strahle, C., Studier-Fischer, A., Fankhauser, L., Kessler, T., Körber, C., Kardorff, M., Ratliff, M., Xie, R., et al. (2019) · Nature · doi:10.1038/s41586-019-1564-x · Cited by 1,197
A neurocentric perspective on glioma invasion
Cuddapah, V. A., Robel, S., Watkins, S., & Sontheimer, H. (2014) · Nature Reviews Neuroscience · doi:10.1038/nrn3765 · Cited by 831
Self-citationGlioblastoma multiforme: Pathogenesis and treatment
Alifieris, C., & Trafalis, D. T. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.05.005 · Cited by 820
Bridges, R. J., Natale, N. R., & Patel, S. A. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01480.x · Cited by 538
Tumor microenvironment in glioblastoma: Current and emerging concepts
Sharma, P., Aaroe, A., Liang, J., & Puduvalli, V. K. (2023) · Neuro-Oncology Advances · doi:10.1093/noajnl/vdad009 · Cited by 314
Metadata
- Authors
- de Groot, J., & Sontheimer, H.
- Venue
- Glia
- Publisher
- Wiley
- Published
- 2010-12-29
- Volume
- 59
- Issue
- 8
- Pages
- 1181-1189
- ISSN
- 0894-1491 (ISSN-L)
- 1098-1136
- OpenAlex
- W2120453252
- Cited by
- 293
- References
- 78
- FWCI
- 6.61
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.